Development, validation and application of an HPLC method for reduced vitamin C qualification in HBOCs solution

References

• Buehler PW, Vallelien F, Mikolajczyk MG, Schoedon G, Schweizer T, Alayash AI, Schaer DJ. 2008. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal. 10:1449–1462.
   PubMed Web of Science ®Google Scholar
• Chen G, Duan Y, Li S, Wang H, Liu J, Yang C. 2013. Antioxidant effects of Vc on human placenta hemoglobin-based oxygen carriers. The14th International Symposium of Blood Substitutes and Oxygen Therapeutics. Chengdu, China.
   Google Scholar
• Chen G, Mo L, Li S, Zhou W, Wang H, Liu J, Yang C. 2015. Separation and determination of reduced vitamin C in polymerized hemoglobin-based oxygen carriers of the human placenta. Artif Cells Nanomed Biotechnol. 43:152–156.
   PubMed Web of Science ®Google Scholar
• Chikvaidze EN, Partskhaladze TM, Gogoladze TV. 2014. Electron spin resonance (ESR/EPR) of free radicals observed in human red hair: a new, simple empirical method of determination of pheomelanin/eumulanin ratio in hair. Magn Reson Chem. 52:377–382.
   PubMed Web of Science ®Google Scholar
• Dorman SC, Kenny CF, Miller L, Hirsch RE, Harrington JP. 2002. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components. Artif Cells Blood Substit Immobil Biotechnol. 30:39–51.
   PubMed Web of Science ®Google Scholar
• Hai CM. 2012. Systems biology of HBOC-induced vasoconstriction. Curr Drug Discov Technol. 9:204–211.
   PubMedGoogle Scholar
• Harrington JP, Orlig K, Zito SL, Wollocko J, Wollocko H. 2010. Structural and redox behavior of OxyVita, a zero-linked polymeric hemoglobin: comparison with natural acellular polymeric hemoglobins. Artif Cells Blood Substit Immobil Biotechnol. 38:64–68.
   PubMed Web of Science ®Google Scholar
• Krukoski DW, Comar SR, Claro LM, Leonart MS, do Nascimento AJ. 2009. Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes. Hematology. 14:168–172.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang H, Wang J, Yang C. 2009. Purification and viral inactivation of hemoglobin from human placenta blood. Artif Cells Blood Substit Immobil Biotechnol. 37:57–60.
   PubMed Web of Science ®Google Scholar
• Putchala MC, Ramani P, Sherlin HJ, Premkumar P, Natesan A. 2013. Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity – a systematic review. Arch Oral Biol. 58:563–574.
   PubMed Web of Science ®Google Scholar
• Roche CJ, Talwar A, Palmer AF, Cabrales P, Gerfen G, Friedman JM. 2015. Evaluating the capacity to generate and preserve nitric oxide bioactivity in highly purified earthworm erythrocruorin: a giant polymeric hemoglobin with potential blood substitute properties. J Biol Chem. 290:99–117.
   PubMed Web of Science ®Google Scholar
• Song BK, Nugent WH, Moon-Massat PF, Pittman RN. 2014. Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model. Microvasc Res. 95:124–130.
   PubMed Web of Science ®Google Scholar
• Wang Q, Hu T, Sun L, Ji S, Zhao D, Liu J, Ma G, Su Z. 2015. CO binding improves the structural, functional, physical and anti-oxidation properties of the PEGylated hemoglobin. Artif Cells Nanomed Biotechnol. 43:18–25.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun L, Ji S, Zhao D, Liu J, Su Z, Hu T. 2014. Reversible protection of Cys-93(β) by PEG alters the structural and functional properties of the PEGylated hemoglobin. Biochim Biophys Acta. 1844:1201–1207.
   PubMed Web of Science ®Google Scholar
• Winslow RM. 2013. Oxygen: the poison is in the dose. Transfusion. 53:424–437.
   PubMed Web of Science ®Google Scholar
• Wu W, Li T, Liu J, Yang C. 2011. Pretreatment before ischemia induction with polymerized human placenta hemoglobin (PolyPHb) attenuates ischemia/reperfusion injury-induced myocardial apoptosis. Artif Cells Blood Substit Immobil Biotechnol. 39:3–6.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhao L, Wang J, Li S, Chen G, Liu J, Yang C. 2013. An optimal polymerization conditions for poly-human placenta hemoglobin with lower mean molecular weight. Artif Cells Nanomed Biotechnol. 41:289–292.
   PubMed Web of Science ®Google Scholar